Updated on 16 December 2025
Fueling the Future of Precision Antimicrobials
CEO at Phagestack GmbH
Pulheim, Germany
About
Phagestack is building an integrated platform for precision antimicrobials, combining proprietary data, AI-driven discovery, experimental validation, and scalable production. By owning the full value chain, we aim to compress development timelines, create multiple revenue streams, and build a defensible position in a rapidly growing global market. We are seeking a lead investor to accelerate scale-up and unlock an existing institutional soft commitment.
Attached files
Similar opportunities
Investment
- Circular Economy
- Growth and Establishment
Wolfram Klingler
Oxara AG
Zurich, Switzerland